Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-arm randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861 (Q68438826)
Jump to navigation
Jump to search
scientific article published on 01 December 1990
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-arm randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861 |
scientific article published on 01 December 1990 |
Statements
Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-arm randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861) (English)
P F Bruning
J M Bonfrèr
J Wildiers
L V Beex
J Schornagel
1 December 1990